Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Management of Hypocalcemia in ESRD Patients on Hemodialysis

Calcium Balance Considerations in ESRD

  • The National Kidney Foundation recommends that calcium balance in ESRD patients is determined by multiple factors: dietary intake, calcium-based phosphate binder use, vitamin D status, dialysate calcium concentration, and ultrafiltration volumes 1
  • Dietary calcium intake is often low in ESRD patients due to dietary restrictions, but calcium-based phosphate binders may contribute significantly to total calcium intake, according to the American Journal of Kidney Diseases 2
  • Patients on intensive hemodialysis who discontinue calcium-based phosphate binders are at particular risk for negative calcium balance when using low calcium dialysate (1.25 mmol/L), as reported by the American Journal of Kidney Diseases 3
  • Negative calcium balance can lead to secondary hyperparathyroidism, increased alkaline phosphatase, and decreased bone mineral density, as stated by the American Journal of Kidney Diseases 4

Evidence-Based Approach to Calcium Replacement

  • A dialysate calcium concentration of 1.5 mmol/L has been shown in mass-balance studies to maintain neutral calcium balance, according to the American Journal of Kidney Diseases 2
  • Higher dialysate calcium concentrations (1.5-1.75 mmol/L) have been shown to reverse increases in alkaline phosphatase and PTH levels in patients on intensive hemodialysis, as reported by the American Journal of Kidney Diseases 3
  • Increasing dialysate calcium concentration from 1.25 to 1.75 mmol/L has been shown to prevent decreases in bone mineral density, according to the American Journal of Kidney Diseases 4

Monitoring Parameters

  • Regular monitoring of serum calcium, phosphate, PTH, and alkaline phosphatase levels is essential, as stated by the American Journal of Kidney Diseases 3
  • Rising bone alkaline phosphatase and PTH levels suggest that higher dialysate calcium may be required, according to the American Journal of Kidney Diseases 2

Potential Benefits and Risks

  • Prevents secondary hyperparathyroidism, as reported by the American Journal of Kidney Diseases 2
  • Maintains bone mineral density, according to the American Journal of Kidney Diseases 4
  • Reduces risk of fragility fractures, as stated by the American Journal of Kidney Diseases 2
  • Theoretical risk of positive calcium balance promoting vascular and soft tissue calcification, as reported by the American Journal of Kidney Diseases 6

Pitfalls to Avoid

  • Using low calcium dialysate (1.25 mmol/L) in patients who have discontinued calcium-based phosphate binders can lead to negative calcium balance, as stated by the American Journal of Kidney Diseases 3
  • Failure to consider all sources of calcium intake (dietary, binders, dialysate) can lead to calcium imbalance, according to the American Journal of Kidney Diseases 2
  • Ignoring rising alkaline phosphatase and PTH levels, which may indicate need for higher dialysate calcium, as reported by the American Journal of Kidney Diseases 3

Algorithm for Managing Hypocalcemia in ESRD

  • First, adjust dialysate calcium to 1.50 mmol/L or higher, as recommended by the American Journal of Kidney Diseases 2
  • Monitor serum calcium, phosphate, PTH and alkaline phosphatase levels, as stated by the American Journal of Kidney Diseases 3